- Report
- June 2025
- 400 Pages
Global
From €4483EUR$4,949USD£3,868GBP
- Report
- June 2025
- 400 Pages
Global
From €4483EUR$4,949USD£3,868GBP
- Report
- June 2025
- 400 Pages
Global
From €4483EUR$4,949USD£3,868GBP
- Report
- June 2025
- 400 Pages
Global
From €4483EUR$4,949USD£3,868GBP
- Report
- January 2025
- 250 Pages
Global
From €4528EUR$4,999USD£3,907GBP
- Report
- July 2024
- 200 Pages
Global
From €4483EUR$4,949USD£3,868GBP
- Report
- February 2024
- 110 Pages
Global
From €4302EUR$4,750USD£3,712GBP
- Report
- June 2025
- 400 Pages
Global
From €4483EUR$4,949USD£3,868GBP
- Report
- June 2025
- 400 Pages
Global
From €4483EUR$4,949USD£3,868GBP
- Report
- January 2025
- 250 Pages
Global
From €4528EUR$4,999USD£3,907GBP
- Report
- May 2023
- 140 Pages
Global
From €4483EUR$4,949USD£3,868GBP
- Report
- April 2024
- 106 Pages
Asia Pacific
From €3125EUR$3,450USD£2,696GBP
- Report
- April 2024
- 101 Pages
Europe
From €3125EUR$3,450USD£2,696GBP
- Report
- April 2024
- 96 Pages
North America
From €3125EUR$3,450USD£2,696GBP
- Report
- April 2024
- 85 Pages
Africa, Middle East
From €3125EUR$3,450USD£2,696GBP
- Report
- April 2024
- 80 Pages
From €3125EUR$3,450USD£2,696GBP
- Report
- November 2024
- 150 Pages
Global
From €4393EUR$4,850USD£3,790GBP
- Report
- May 2025
- 80 Pages
Denmark, Finland, ... Denmark, Finland, Iceland, Norway, Sweden
From €2581EUR$2,850USD£2,227GBP
- Report
- January 2025
- 146 Pages
Global
From €3578EUR$3,950USD£3,087GBP
- Report
- November 2023
- 148 Pages
Global
From €4031EUR$4,450USD£3,478GBP

The AIDS market within the context of Allergy and Immunology is focused on the development of treatments and therapies for HIV/AIDS. This includes the development of drugs to treat HIV infection, as well as vaccines and other therapies to prevent the spread of the virus. Additionally, research is being conducted to better understand the mechanisms of HIV infection and the development of new treatments.
The market is highly competitive, with many companies vying for a share of the market. Companies such as Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and ViiV Healthcare are all major players in the AIDS market. Other companies such as AbbVie, Janssen, and Pfizer are also involved in the development of treatments and therapies for HIV/AIDS. Show Less Read more